• Explore /
  • Poster
  • / Safety of trifluridine/tipiracil (TAS-102) in combination with temozolomide for metastatic neuroendocrine tumors.

Safety of trifluridine/tipiracil (TAS-102) in combination with temozolomide for metastatic neuroendocrine tumors.

Abstract Poster

Authors

null

Nataliya Volodymyrivna Uboha

University of Wisconsin Carbone Cancer Center, Madison, WI

Nataliya Volodymyrivna Uboha , Dustin A. Deming , Sam Joseph Lubner , Daniel Mulkerin , Jens C. Eickhoff , Noelle K. LoConte

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02943733

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr TPS549)

DOI

10.1200/JCO.2018.36.4_suppl.TPS549

Abstract #

TPS549

Poster Bd #

R4

Abstract Disclosures

Similar Posters

First Author: Nataliya Volodymyrivna Uboha

First Author: Robert Lance Fine

First Author: Evan Justin Walker

First Author: Yelena Y. Janjigian